Baird Medical Investment Holdings Ltd
BDMD0.920USD
+0.016+1.74%
Handelsschluss 02/06, 16:00（ET）Kurse um 15 Minuten verzögert
24.44MMarktkapitalisierung
VerlustKGV TTM
mehr Informationen über Baird Medical Investment Holdings Ltd Unternehmen
Baird Medical Investment Holdings Ltd is a company mainly engaged in the microwave ablation medical device business. The Company is mainly engaged in the provision of microwave ablation medical device. The medical devices are used for treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer and breast lumps.
Baird Medical Investment Holdings Ltd Informationen
BörsenkürzelBDMD
Name des UnternehmensBaird Medical Investment Holdings Ltd
IPO-datumDec 13, 2021
CEOWu (Haimei)
Anzahl der mitarbeiter143
WertpapierartOrdinary Share
GeschäftsjahresendeDec 13
Addresse18/F, Ovest
StadtGUANGZHOU
BörseNASDAQ OMX - NASDAQ BASIC
LandChina
Postleitzahl- -
Telefon
Websitehttps://ir.bairdmed.com/
BörsenkürzelBDMD
IPO-datumDec 13, 2021
CEOWu (Haimei)
Führungskräfte von Baird Medical Investment Holdings Ltd
Name
Name/Position
Position
Aktienbesitz
Veränderung
Ms. Haimei Wu
Ms. Haimei Wu
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
18.30M
+18295281.00%
Mr. Joe Ragan
Mr. Joe Ragan
Director
Director
--
--
Mr. Wei Hou
Mr. Wei Hou
Director
Director
--
--
Ms. Quan Qiu
Ms. Quan Qiu
Chief Administrative Officer, Director
Chief Administrative Officer, Director
--
--
Prof. Mingzhao (Michael) Xing
Prof. Mingzhao (Michael) Xing
Independent Director
Independent Director
--
--
Mr. Lijian Xu
Mr. Lijian Xu
Independent Director
Independent Director
--
--
Ms. Gabrielle Bilciu-Wolfson
Ms. Gabrielle Bilciu-Wolfson
Independent Director
Independent Director
--
--
Mr. Rongjian Lu
Mr. Rongjian Lu
Chief Technology Officer, Deputy General Manager
Chief Technology Officer, Deputy General Manager
--
--
Ms. Jie Li
Ms. Jie Li
Acting Chief Financial Officer
Acting Chief Financial Officer
--
--
Mr. Jianwei Yuan
Mr. Jianwei Yuan
Production Department Manager
Production Department Manager
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Ms. Haimei Wu
Ms. Haimei Wu
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
18.30M
+18295281.00%
Mr. Joe Ragan
Mr. Joe Ragan
Director
Director
--
--
Mr. Wei Hou
Mr. Wei Hou
Director
Director
--
--
Ms. Quan Qiu
Ms. Quan Qiu
Chief Administrative Officer, Director
Chief Administrative Officer, Director
--
--
Prof. Mingzhao (Michael) Xing
Prof. Mingzhao (Michael) Xing
Independent Director
Independent Director
--
--
Mr. Lijian Xu
Mr. Lijian Xu
Independent Director
Independent Director
--
--
Umsatzaufteilung
Währung: USDAktualisiert: Tue, Jan 6
Währung: USDAktualisiert: Tue, Jan 6
FY2024
FY2023
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
MWA Needles
33.83M
91.33%
MWA Therapeutic Apparatus
3.20M
8.64%
Other Medical Devices
9.83K
0.03%
Nach RegionUSD
Name
Umsatz
Anteil
China (Mainland)
37.04M
100.00%
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
MWA Needles
33.83M
91.33%
MWA Therapeutic Apparatus
3.20M
8.64%
Other Medical Devices
9.83K
0.03%
Aktionärsstatistik
Aktualisiert: Sat, Jan 3
Aktualisiert: Sat, Jan 3
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
Wu (Haimei)
49.82%
ExcelFin SPAC LLC
13.00%
Grand Fortune Capital (H.K.) Co, Ltd.
6.71%
Periscope Capital
0.34%
Highbridge Capital Management, LLC
0.34%
Andere
29.79%
Aktionäre
Aktionäre
Anteil
Wu (Haimei)
49.82%
ExcelFin SPAC LLC
13.00%
Grand Fortune Capital (H.K.) Co, Ltd.
6.71%
Periscope Capital
0.34%
Highbridge Capital Management, LLC
0.34%
Andere
29.79%
Aktionärstypen
Aktionäre
Anteil
Individual Investor
49.82%
Corporation
19.71%
Investment Advisor/Hedge Fund
0.54%
Hedge Fund
0.47%
Investment Advisor
0.09%
Research Firm
0.04%
Andere
29.34%
Institutionelle Beteiligung
Aktualisiert: Mon, Dec 8
Aktualisiert: Mon, Dec 8
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q4
34
465.80K
9.90%
--
2025Q3
47
465.80K
18.84%
-72.37K
2025Q2
50
538.17K
21.64%
+180.74K
2025Q1
80
357.43K
67.10%
-16.79M
2024Q4
85
305.49K
75.32%
+42.45K
2024Q3
88
263.04K
299.72%
-979.92K
2024Q2
90
1.24M
285.03%
-389.76K
2024Q1
94
1.63M
272.11%
-20.00M
2023Q4
94
1.73M
289.40%
-2.99M
2023Q3
93
4.71M
469.75%
-226.48K
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
Wu (Haimei)
18.30M
68.9%
+18.30M
--
May 13, 2025
ExcelFin SPAC LLC
4.77M
17.98%
-976.59K
-16.98%
May 13, 2025
Grand Fortune Capital (H.K.) Co, Ltd.
2.46M
9.28%
+2.46M
--
May 13, 2025
Periscope Capital
125.00K
0.47%
--
--
Sep 30, 2025
Highbridge Capital Management, LLC
125.00K
0.47%
--
--
Sep 30, 2025
Northern Trust Investments, Inc.
48.29K
0.18%
-4.15K
-7.92%
Sep 30, 2025
Citadel Advisors LLC
46.53K
0.18%
+46.53K
--
Sep 30, 2025
UBS Financial Services, Inc.
65.82K
0.25%
-25.63K
-28.03%
Sep 30, 2025
Geode Capital Management, L.L.C.
25.44K
0.1%
--
--
Sep 30, 2025
Virtu Americas LLC
14.04K
0.05%
-12.32K
-46.73%
Sep 30, 2025
Mehr Anzeigen
Verbundene ETFs
Name
Anteil
Keine Daten
Dividende
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten
Aktien-Split
Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
